Biosimilar Newsletter Archive

  1. 03.26.26 -- A simple, helpful look at PUPSIT implementation. 3/26/2026

    03/26/26 Biosimilar Development Newsletter

  2. 03.26.26 -- A Practical Look At Modern Downstream Processing For Biologics 3/26/2026
    03/26/26 Biosimilar Development Newsletter
  3. 03.24.26 -- Stop Engineering Cells. Start Engineering Glycans. 3/24/2026

    03/24/26 Biosimilar Development Newsletter

  4. 03.19.26 -- Struggling with mAb aggregation and other impurities? 3/19/2026

    03/19/26 Biosimilar Development Newsletter

  5. 03.19.26 -- A Novel In Vitro Glycosylation Approach For Difficult PTMs 3/19/2026
    03/19/26 Biosimilar Development Newsletter
  6. 03.05.26 -- Phase-Appropriate Control Lessons For mAb/ADC Manufacturers 3/5/2026
    03/05/26 Biosimilar Development Newsletter
  7. 02.26.26 -- New ISPE Framework Targets Uncertainty In Pharma's AI Deployment 2/26/2026
    02/26/26
  8. 02.19.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation? 2/19/2026
    02/19/26 Biosimilar Development Newsletter
  9. 02.12.26 -- Building Enterprise Resilience From QRM Signals 2/12/2026
    02/12/26 Biosimilar Development Newsletter
  10. 01.29.26 -- The Latest In Upstream HCP Mitigation 1/29/2026
    01/29/26 Biosimilar Development Newsletter